Junling Zhuang

1.1k citations
87 papers · 665 indexed · h-index 13
Topics
Multiple Myeloma Research and Treatments (33 papers)Protein Degradation and Inhibitors (18 papers)Peptidase Inhibition and Analysis (9 papers)
Partner nations
ChinaUnited StatesIndia

In The Last Decade

Junling Zhuang

70 papers receiving 659 citations

Peers

Junling Zhuang
Comparison fields: 5 of 87
  • Hematology 311
  • Oncology 268
  • Molecular Biology 229
  • Immunology 123
  • Genetics 77
Replace Akihito Fujimi with:
Akihito Fujimi Japan
Hana Safah United States
Shingo Wakatsuki Japan
Dale Frank United States
Hidemitsu Kurosawa Japan
Yasutaka Hoshi Japan
Qin Huang United States
Chikako Ohwada Japan
Mineo Kurokawa Japan
Stefan Gröschel Germany
Junling Zhuang relative to Akihito Fujimi Japan Akihito Fujimi's profile →
Citations per field
00.5×3.0×
Akihito Fujimi · 1×
Citations per year

Countries citing papers authored by Junling Zhuang

Since Specialization
Citations

This map shows the geographic impact of Junling Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junling Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junling Zhuang more than expected).

Fields of papers citing papers by Junling Zhuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junling Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junling Zhuang. The network helps show where Junling Zhuang may publish in the future.

Co-authorship network of co-authors of Junling Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Junling Zhuang. A scholar is included among the top collaborators of Junling Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junling Zhuang. Junling Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 0
4 3
5 0
6 8
7 1
8 0
9 0
10 0
11 0
12 1
13 29
14 0
15 16
16 3
17
[A multicenter retrospective etiological analysis of 601 patients with hemophagocytic lymphohistiocytosis in China].
6
18 98
19
Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
1
20
Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche
2

About Junling Zhuang

Junling Zhuang is a scholar working on Hematology, Genetics and Oncology, having authored 87 papers that have together received 665 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (33 papers), Protein Degradation and Inhibitors (18 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Hematology (311 citations), Oncology (268 citations) and Genetics (77 citations). Junling Zhuang has collaborated with scholars based in China, United States and India. Frequent co-authors include Claire M. Edwards, Gregory R. Mundy, Seint T. Lwin, Daobin Zhou, James Edwards, Xiangli Yang, Jianghong Zhang, Bing Han, Miao Chen and Jianhua Du. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026